Reply to K. Zaman et al.
Beth Israel Deaconess Medical Center, Boston, MA.
Nadine
N
Tung
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011960:Receptors, Estrogen / Q000378:metabolism*
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen